Join us to explore how AI is reshaping guideline development and clinical decision-making. Experts will discuss how to harness the strengths of LLMs while preserving clinician autonomy, minimizing bias, & ensuring evidence continues guiding care. Sign up: nejm.ai/4xeAutH
ALT Dark navy image with an illustration of a doctor using technology to evaluate diagnostic and imaging results. Below the illustration reads the following:
Reinventing Clinical Guidelines in the AI Era
October 21, 2026
Free Virtual Event
The NEJM AI logo is centered at bottom.
A new study examines whether the clinical care recommended by contemporary LLMs carries a different cost than the care recommended by treating physicians, and whether that difference is influenced by how the models are prompted. Learn more: nejm.ai/4i18zYw
ALT This image is a diagram titled "Study Design" for a clinical presentation MTS_0481. It outlines a comparative study across four scenarios: Physician, AI-Generalist, AI-Cost-Aware, and AI-Parsimonious. Each scenario includes details on diagnosis, diagnostic orders, and costs in US dollars. The scenarios focus on acute bronchiolitis. The diagram also features stages like case selection, note splitting, plan generation, order extraction, and Medicare pricing.
On @NEJM_AI Grand Rounds, @DrXiaoLiu is excited by the possibility of combining medical knowledge to uncover new biomarkers, disease phenotypes, and treatment-response patterns that challenge today’s categories. Listen to the full episode: nejm.ai/ep46
A new editorial discusses the need to assess the use of AI technology to understand how it impacts what matters to the patient and to society. Full editorial: nejm.ai/4zyYg59
ALT The image features a quote from an NEJM AI editorial by Adam A. Markovitz , M.D., Ph.D., and Alexander M. Chaitoff, M.D., M.P.H.: " It is easy to imagine AI lowering spending . . . . It is just as easy to imagine AI increasing spending.” A colorful silhouette of a face with horizontal lines is on the left. The NEJM AI logo is at the bottom right.
A new Perspective suggests that medical education must adapt as AI shifts clinical expertise from unaided cognitive performance toward the ability to evaluate, supervise, and appropriately defer to increasingly capable AI systems. Learn more: nejm.ai/4ybNSiw
ALT This figure shows a hypothetical clinical interface in which AI generates diagnostic and management recommendations while the physician evaluates their appropriateness, incorporates patient priorities, and judges when to defer or intervene. Displayed findings and confidence estimates are illustrative.
On @NEJM_AI Grand Rounds, @DrXiaoLiu imagines clinicians becoming “companions of experience” — helping patients through deterioration, uncertainty, treatment failure, recovery, and life-changing diagnoses. Hear more from Dr. Liu: nejm.ai/ep46
Original Article by B. Lahrmann et al.: Closing the Automation Gap in HPV-Based Cervical Cancer Screening: Independent External Validation of an AI Model for Dual-Stain Triage nejm.ai/4xRsEXe#ArtificialIntelligence#AIinMedicine
ALT A flowchart consisting of three panels showing the iterative development, validation, and locked evaluation of an ensemble-based AI system. Panel A shows population-based outcome studies that provided whole-slide images of p16/Ki-67 DS cytology prepared with SurePath or ThinPrep. Panel B shows image tiles spanning unstable LH ranges being extracted in batches and processed using Cytoreader-Core for automated labeling. Panel C shows relabeled tiles being used to construct a deep ensemble with predefined parameters.
Today’s health care leaders face fundamental disruptions in their ecosystems and a convergence of challenges across countries requiring new leadership approaches that have not yet been explored in depth. Read the full Commentary: nej.md/3U5A8Ye
ALT The image contains text on a gradient purple and blue background with a quotation: "The rapidly evolving technology landscape requires leaders to thoughtfully integrate digital health tools and artificial intelligence within their organizations, which can be challenging in established organizations with entrenched policies and workflows."
Below the quote reads the article headline "New Leadership Approaches for Health System Transformation in a Time of Rapid Change" by R. Bonesteel, et al.
The image is from NEJM Catalyst | Innovations in Care Delivery.
ALT The image is page 1 of the editorial "Where Are the Prepared Minds? The Impact of AI on
Scientific Thinking" published in NEJM AI. A dark blue banner at the bottom encourages readers to access the full editorial at ai.nejm.org.
On @NEJM_AI Grand Rounds, @DrXiaoLiu discusses how she moved from academic AI and clinical ophthalmology into product development because she wanted firsthand experience of the other side of the evidence pipeline. Full episode: nejm.ai/ep46
ALT A bar chart showing the average large language model–patient agreement (blue bars) compared with average human proxy–patient agreement (horizontal brown and black dotted lines) across 10 repetition trials (±95% confidence intervals).
ALT A bar chart showing the mean adjudicator score (±95% bootstrapped confidence intervals) assessing the accuracy of large language model value profile generation (score out of 10) for each patient in the electronic health record cohort across the three reading levels: fifth grade, eighth or ninth grade, and college graduate level.
ALT A bar chart showing the adjudication of large language model treatment recommendations at the three reading levels (fifth grade, eighth/ninth grade, or college graduate level) averaged across adjudicators and the 35 electronic health record cohort patients.
To more efficiently synthesize lengthy patient charts comprising demographics, medical and behavioral history, health-related social needs, care team interaction history, and care plan info, Pair Team developed and deployed an AI Patient Summary tool. 👉 nej.md/4yQ4aOZ
A new study explores the use of AI to automate p16/Ki-67 dual-stain cytology evaluation, a key step in triaging HPV-positive patients during cervical cancer screening. Learn more: nejm.ai/4xRsEXe
ALT A collection of digital tissue samples is being analyzed by a stylized robotic device. The headline reads: "Closing the Automation Gap in HPV-Based Cervical Cancer Screening: Independent External Validation of an AI Model for Dual-Stain Triage," dated September 24, 2026.
No smoke and mirrors. In the latest episode of the @NEJM_AI Grand Rounds podcast, @DrXiaoLiu argues that medical AI reporting standards should make methods visible rather than dictate them. Hear more from Dr. Liu: nejm.ai/ep46
A new editorial by Dr. @RoxanaDaneshjou argues that scientific trainees should first develop foundational skills before relying on AI, which should serve as a complementary tool, not a replacement for reasoning. Read the full editorial: nejm.ai/3TKfJbp
ALT The image features a quote from an NEJM AI editorial by Roxana Daneshjou, M.D., Ph.D.: "As trainees move to become more seasoned scientists, they can choose how to safely incorporate AI without compromising their cognitive capabilities." A colorful silhouette of a face with horizontal lines is on the left. The NEJM AI logo is at the bottom right.
Perspective by I. Nenadic et al.: From Technical Performance to Clinical Readiness: A Phase-Based Framework for Evidence Standards in Clinical Artificial Intelligence nejm.ai/4yIi4CK#AIinMedicine
ALT A quote from a Perspective published in NEJM AI reads as follows: “Clinical AI is unlikely to follow a single regulatory or evidentiary template. . . . Even so, a staged evidentiary model analogous in principle to those used for drugs and devices offers a practical way to align innovation with clinical readiness.” The Perspective is titled “From Technical Performance to Clinical Readiness: A Phase-Based Framework for Evidence Standards in Clinical Artificial Intelligence” and the authors are I. Nenadic et al. The background color is dark blue and includes the NEJM AI logo.
ALT A quote from a Policy Corner article published in NEJM AI reads as follows: “In a rapidly evolving clinical AI marketplace, coordinated action between the CMS and FDA is necessary to balance fiscally responsible reimbursement standards with the preservation of market competition and diversity.” The article is titled “How Repeal of the NTAP Alternative Pathway will Impact U.S. Clinical AI Innovation” and the authors are A. Wong et al. The background color is orange and includes the NEJM AI logo.
Individuals with complex medical and social needs require targeted, coordinated, and whole-person care. Learn about @yourpairteam's AI tool that quickly and accurately summarizes a diverse set of data sources to identify their health-related social needs: nej.md/4yQ4aOZ
ALT A quote on a purple background states: "Health-related social needs are dynamic and nuanced, and data about them are often unstructured, creating an ongoing challenge for analysis and synthesis." Below is the Case Study title "An AI-Based Whole-Person Care Summarization Tool for Care Management Providers" by J. Mulligan et al. The NEJM Catalyst logo is at the bottom.